RESMED INC
Ticker: 943819
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.4K+0.6% | 1.4K+6.5% | 1.3K+3.4% | 1.3K+0.8% | 1.3K+4.7% | 1.2K+2.3% | 1.2K+2.9% | 1.2K |
| Total Income | 1.4K+0.6% | 1.4K+6.5% | 1.3K+3.4% | 1.3K+0.8% | 1.3K+4.7% | 1.2K+2.3% | 1.2K+2.9% | 1.2K |
| EXPENSES | ||||||||
| Expenditure | 931.60+0.0% | 931.15+4.7% | 889.05+2.7% | 865.47+0.1% | 864.85+3.3% | 837.20+1.8% | 822.40-7.4% | 887.71 |
| Tax | 103.58+0.0% | 103.56+5.4% | 98.26+86.6% | 52.65-28.6% | 73.70+2.2% | 72.14-3.7% | 74.93+47.9% | 50.65 |
| PROFIT | ||||||||
| PBT | 502.31+1.2% | 496.15+11.0% | 446.79+7.0% | 417.69-0.2% | 418.32+9.1% | 383.50+2.2% | 375.42+44.7% | 259.45 |
| Net Profit | 398.73+1.6% | 392.59+12.6% | 348.54-4.5% | 365.04+5.9% | 344.62+10.7% | 311.36+3.6% | 300.49+43.9% | 208.80 |
| KEY METRICS | ||||||||
| OPM % | 34.92%+0.36pp | 34.56%+1.12pp | 33.43%+0.43pp | 33.00%+0.46pp | 32.54%+0.91pp | 31.63%+0.34pp | 31.29%+7.64pp | 23.66% |
| NPM % | 27.86%+0.26pp | 27.59%+1.50pp | 26.10%-2.16pp | 28.26%+1.38pp | 26.88%+1.45pp | 25.43%+0.32pp | 25.10%+7.15pp | 17.96% |
| EPS | 2.74+1.9% | 2.69+13.0% | 2.38-4.4% | 2.49+6.0% | 2.35+10.8% | 2.12+3.9% | 2.04+43.7% | 1.42 |
Corporate Events
Board MeetingRMD
20266Aug
Board Meeting
Fourth Quarter Fiscal Year 2026 Earnings Webcast — Resmed to…
SEC Filing ↗ Board MeetingRMD
20261Jun
Board Meeting
Resmed completes acquisition of Noctrix Health, Inc. Resmed…
SEC Filing ↗ Board MeetingRMD
20264May
Board Meeting
CFO Transition — Aaron Bloomer appointed as Chief Financial …
SEC Filing ↗